Expanded T cell clones with lymphoma driver somatic mutations in refractory celiac disease

<p>Processed data and scripts for "Expanded T cell clones with lymphoma driver somatic mutations in refractory celiac disease".</p> <p>Intestinal inflammation continues in a subset of celiac disease (CD) patients despite a gluten-free<br>diet. Here, by applying multiomic single cell analysis to duodenal biopsies, we find low-grade<br>malignancies with lymphoma driver mutations in refractory CD type 2 (RCD2) patients comprise<br>surface CD3 negative (sCD3-) lymphocytes stalled at an innate lymphoid cell (ILC) - progenitor<br>T cell stage undergoing extensive TCR recombination. In people with refractory CD type 1<br>(RCD1), who currently lack explanation, we discover sCD3+ T cells with lymphoma driver<br>mutations forming large clones displaying inflammatory and cytotoxic molecular profiles in 6 of<br>10 individuals, and a single small clone in 1 of 4 active recently diagnosed CD cases. Accumulation<br>of driver-mutated T cells and sCD3- progenitors may explain chronic, non-responsive<br>autoimmunity.</p>

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-01
DOI
https://doi.org/10.5281/zenodo.14836406
Primary Topic
Celiac Disease Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expanded T cell clones with lymphoma driver somatic mutations in refractory celiac disease

Zenodo (CERN European Organization for Nuclear Research)
Celiac Disease Research and Management
article

Expanded T cell clones with lymphoma driver somatic mutations in refractory celiac disease

article en

Abstract

<p>Processed data and scripts for "Expanded T cell clones with lymphoma driver somatic mutations in refractory celiac disease".</p> <p>Intestinal inflammation continues in a subset of celiac disease (CD) patients despite a gluten-free<br>diet. Here, by applying multiomic single cell analysis to duodenal biopsies, we find low-grade<br>malignancies with lymphoma driver mutations in refractory CD type 2 (RCD2) patients comprise<br>surface CD3 negative (sCD3-) lymphocytes stalled at an innate lymphoid cell (ILC) - progenitor<br>T cell stage undergoing extensive TCR recombination. In people with refractory CD type 1<br>(RCD1), who currently lack explanation, we discover sCD3+ T cells with lymphoma driver<br>mutations forming large clones displaying inflammatory and cytotoxic molecular profiles in 6 of<br>10 individuals, and a single small clone in 1 of 4 active recently diagnosed CD cases. Accumulation<br>of driver-mutated T cells and sCD3- progenitors may explain chronic, non-responsive<br>autoimmunity.</p>

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 38%
Celiac Disease Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.